Efficacy of a Non-invasive Pelvic Floor Muscle Trainer for Treatment of Stress Urinary Incontinence
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Stress Urinary Incontinence
- Sponsor
- Pelex
- Enrollment
- 5
- Locations
- 1
- Primary Endpoint
- Change in stress urinary incontinence symptoms
- Status
- Completed
- Last Updated
- 3 years ago
Overview
Brief Summary
The goal of this clinical trial is to assess the efficacy and usability of the electromyography component of the company's pelvic health product in a patient population with stress urinary incontinence. The main questions it aims to answer are:
Does treatment with the device under study improve symptoms of stress urinary incontinence as measured by the ICIQ?
Participants will be given one of the devices under study, in addition to educational materials on use of the device, and a treatment schedule. Participants will perform a standardized biofeedback-mediated pelvic floor muscle training program with the study device 10 minutes a day, five times a week for 4 weeks. There will be a mid-study check in to assure all devices are functioning appropriately. At the end of the study, participants will complete a post-treatment urinary incontinence symptom questionnaire(ICIQ).
Detailed Description
This will be a prospective cohort study of women \> 18 years of age with symptoms of stress urinary incontinence, recruited via an online recruitment tool. After screening, patients meeting inclusion criteria will be given a study brochure, and then given instructions on how to indicate desire to participate in the study. The patient will then be contacted for study participation, including explanation of study and details and completion of Informed Consent. Participants will then complete a pre-treatment urinary incontinence symptom questionnaire(ICIQ). After completion of the above, the participants will then be given one of the devices under study, in addition to educational materials on use of the device, and a treatment schedule. Participants will perform a standardized biofeedback-mediated pelvic floor muscle training program with the study device 10 minutes a day, five times a week for 4 weeks. There will be a mid-study check in to assure all devices are functioning appropriately. At the end of the study, participants will complete a post-treatment urinary incontinence symptom questionnaire(ICIQ). Endpoint of the study will be change in stress urinary incontinence symptoms as measured by the ICIQ. The ICIQ will be collected at 2 time points: before study entry, and at study close.
Investigators
Eligibility Criteria
Inclusion Criteria
- •18 years of age or older
- •Documented symptoms of predominantly stress urinary incontinence as determined by the ICIQ questionnaire
Exclusion Criteria
- •History of pelvic or lower back surgery
- •Pregnancy or less than 12 months post partum
- •History of physician-supervised PFMT
- •History of Kegel exercises greater than once a month
- •History of prior operative delivery
- •Self-reported history of pelvic organ prolapse stage II or greater
Outcomes
Primary Outcomes
Change in stress urinary incontinence symptoms
Time Frame: 4 weeks
Patients were given the ICIQ-UI SF, the standard assessment tool for stress and urge urinary incontinence, both before initiation and at the end of study. The difference between the two scores was then assessed to determine whether an change in stress urinary incontinence symptoms occurred after use of the device. ICIQ is the International Consultation on Incontinence Questionnaire - Urinary Incontinence Short Form is a four question survey to "evaluate the frequency, severity and impact on quality of life (QoL) of urinary incontinence in men and women." It has a maximum and minimum score of 21 and 0 respectively. Higher scores reflect more significant urinary incontinence symptoms.